glp 1 inventor We are honoured to welcome Dr. Lotte Bjerre Knudsen as our speaker for #ARDD2025! Lotte is a co-inventor of the long-acting GLP-1, liraglutide, and has led all biology research programs from diabetes How Lotte Bjerre Knudsen helped

It's the compound with robust Phase 3 evidence for weight reduction (20.9% mean body weight loss at 72 weeks in the SURMOUNT-1 trial)

However, following baseline we only assessed dietary intake for 4 consecutive days prior to each of the two testing sessions at weeks 4 and 8 (8 out of 56 days) which constitutes a small portion of the dietary intake, approximately 86%, not accounted for during the study

Lipotropic injections deliver the amino acids and B vitamins it needs to do that job efficiently

While results may vary, interest in this application continues to rise

Is Cagrilintide better than semaglutide alone

To keep it light and easy, try cottage cheese with berries, a sprinkle of nuts or seeds, or a drizzle of honey if sweetness sounds appealing